Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.430
+0.010 (0.70%)
At close: Jul 9, 2026, 4:00 PM EDT
1.445
+0.015 (1.05%)
After-hours: Jul 9, 2026, 4:41 PM EDT
Enveric Biosciences Employees
As of December 31, 2025, Enveric Biosciences had 6 total employees, including 5 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
6
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,929,997
Market Cap
5.27M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 6 | 0 | - | 5 | 1 |
| Dec 31, 2024 | 6 | -1 | -14.29% | 5 | 1 |
| Dec 31, 2023 | 7 | -19 | -73.08% | 7 | 0 |
| Dec 31, 2022 | 26 | 2 | 8.33% | 25 | 1 |
| Dec 31, 2021 | 24 | 21 | 700.00% | 23 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 39 |
| HCW Biologics | 35 |
| Aptevo Therapeutics | 33 |
| Cardio Diagnostics Holdings | 17 |
| Soligenix | 14 |
| Processa Pharmaceuticals | 12 |
| NuCana | 12 |
| Dermata Therapeutics | 9 |
ENVB News
- 10 days ago - Enveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit - Business Wire
- 23 days ago - Enveric Biosciences Announces Participation in 2026 BIO International Convention - Business Wire
- 4 weeks ago - Enveric Biosciences to Participate in the UBS 3rd Virtual CNS Day - Business Wire
- 5 weeks ago - Enveric Biosciences initiates IND-enabling Genotoxicity studies of EB-003 - TheFly
- 5 weeks ago - Enveric Biosciences Initiates Investigational New Drug (IND)-enabling Genotoxicity Studies of Lead Neuroplastogen Candidate EB-003 - Business Wire
- 7 weeks ago - Enveric Biosciences reports preclinical results from analysis of EB-003 - TheFly
- 7 weeks ago - Enveric Biosciences Reports Positive Preclinical Results from Phototoxicity Analysis for Lead Neuroplastogen Candidate EB-003 - Business Wire
- 7 weeks ago - Enveric Biosciences reports Q1 EPS ($1.08) vs. ($14.58) last year - TheFly